Latest Tax Incentives News

Actinogen Medical has received an additional $1.87 million R&D tax incentive rebate, bringing its total FY 2025 rebate to $7.36 million, while its Alzheimer’s phase 2b/3 trial progresses with promising safety results.

Argenica Therapeutics has reported a significant increase in its half-year loss to $3.82 million, driven by reduced revenue and higher research and development expenses. The company continues to invest heavily in its neuroprotective drug candidate ARG-007 amid ongoing clinical trials.

PMET Resources has announced a significant capital raise of up to C$130 million through a public offering and a flow-through private placement to advance its Shaakichiuwaanaan critical minerals project in Quebec. The funds will support updated feasibility studies and exploration, aiming to de-risk the path to a Final Investment Decision.

Elixir Energy has reached 2,320 metres in the Lorelle-3 appraisal well and is preparing to drill the reservoir section targeting the Dunk member of the Tinowon Sandstone, with flow testing planned before mid-2026.

Livium Ltd announces a further A$335,000 distribution from its 50% stake in the LieNA joint venture, following receipt of a substantial R&D tax incentive rebate for FY25. The joint venture remains well-funded through FY27, supporting ongoing lithium extraction technology development.

Redstone Resources has reported significant new high-grade copper intersections at unprecedented depths beneath its Tollu Copper deposit in Western Australia, hinting at a larger magmatic sulphide system. The company also secured government grants and raised capital to advance exploration.

EcoGraf Limited has marked significant progress in its Epanko Graphite Project financing and expansion plans, while initiating a strategic gold farm-in agreement with AngloGold Ashanti in Tanzania.

Actinogen Medical has completed enrolment for its pivotal XanaMIA Alzheimer's trial ahead of schedule, with a positive interim analysis supporting continuation. The company is gearing up for an open-label extension and advancing commercial and partnership strategies.

Careteq Limited reported a disciplined operating cash flow in Q2 FY26 with strong growth in its Embedded Health Solutions segment and ongoing resolution of an ATO tax incentive dispute.

BluGlass Limited has extended its contract with the U.S. Department of War by A$1.05 million and appointed a refreshed Board to accelerate its commercial growth in visible laser technology. The company is advancing its GaN laser portfolio amid a US$100 million project pipeline and ongoing R&D investments.

Critica Limited has confirmed repeatable high-grade rare earth product quality at its Jupiter Project, delivering an 86% TREO concentrate and demonstrating gallium by-product potential. The company also secured an oversubscribed $8 million placement to fund pilot operations and a scoping study.

Latrobe Magnesium has resolved a critical manufacturing defect at its Demonstration Plant, enabling Magnesium Oxide production to resume, while securing key financial support for its commercial expansion plans.